181 related articles for article (PubMed ID: 34538241)
1. Low socioeconomic position is a risk factor for delay to treatment and mortality of testicular cancer patients in Hungary, a prospective study.
Küronya Z; Fröhlich G; Ladányi A; Martin T; Géczi L; Gyergyai F; Horváth O; Kiszner G; Kovács Á; Dienes T; Lénárt E; Nagyiványi K; Szarvas T; Szőnyi M; Tóth A; Biró K
BMC Public Health; 2021 Sep; 21(1):1707. PubMed ID: 34538241
[TBL] [Abstract][Full Text] [Related]
2. Changing incidence and delay of testicular cancer in southern Norway (1981-1992).
Hernes EH; Harstad K; Fosså
Eur Urol; 1996; 30(3):349-57. PubMed ID: 8931969
[TBL] [Abstract][Full Text] [Related]
3. The incidence, prognosis, clinical and histological characteristics, treatment, and outcome of patients with bilateral germ cell testicular cancer in Hungary.
Géczi L; Gomez F; Bak M; Bodrogi I
J Cancer Res Clin Oncol; 2003 May; 129(5):309-15. PubMed ID: 12748851
[TBL] [Abstract][Full Text] [Related]
4. The oncogene Gankyrin is expressed in testicular cancer and contributes to cisplatin sensitivity in embryonal carcinoma cells.
Camacho-Moll ME; Macdonald J; Looijenga LHJ; Rimmer MP; Donat R; Marwick JA; Shukla CJ; Carragher N; Jørgensen A; Mitchell RT
BMC Cancer; 2019 Nov; 19(1):1124. PubMed ID: 31744479
[TBL] [Abstract][Full Text] [Related]
5. Baseline characteristics and patterns of care in testicular cancer patients: first data from the Swiss Austrian German Testicular Cancer Cohort Study (SAG TCCS).
Rothermundt C; Thurneysen C; Cathomas R; Müller B; Mingrone W; Hirschi-Blickenstorfer A; Wehrhahn T; Ruf C; Rothschild S; Seifert B; Terbuch A; Grassmugg T; Woelky R; Fankhauser C; Kunit T; Fischer N; Inauen R; Kamradt J; Ziegler K; Haynes A; Jüni P; Gillessen S
Swiss Med Wkly; 2018; 148():w14640. PubMed ID: 30044478
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for testicular cancer--differences between pure non-seminoma and mixed seminoma/non-seminoma?
Aschim EL; Haugen TB; Tretli S; Daltveit AK; Grotmol T
Int J Androl; 2006 Aug; 29(4):458-67. PubMed ID: 16487404
[TBL] [Abstract][Full Text] [Related]
7. The clinical features and management of testicular germ cell tumours in patients aged 60 years and older.
Wheater MJ; Manners J; Nolan L; Simmonds PD; Hayes MC; Mead GM
BJU Int; 2011 Dec; 108(11):1794-9. PubMed ID: 21627751
[TBL] [Abstract][Full Text] [Related]
8. Testosterone deficiency in testicular germ-cell cancer patients is not influenced by oncological treatment.
Pühse G; Secker A; Kemper S; Hertle L; Kliesch S
Int J Androl; 2011 Oct; 34(5 Pt 2):e351-7. PubMed ID: 21062302
[TBL] [Abstract][Full Text] [Related]
9. Bilateral testicular germ cell tumors in patients treated for clinical stage I non-seminoma within two risk-adapted SWENOTECA protocols.
Tandstad T; Solberg A; Håkansson U; Stahl O; Haugnes HS; Oldenburg J; Dahl O; Kjellman A; Angelsen A; Cohn-Cedermark G;
Acta Oncol; 2015 Apr; 54(4):493-9. PubMed ID: 25192551
[TBL] [Abstract][Full Text] [Related]
10. Testicular cancer: a 13-year retrospective review of ethnic disparities in the Waikato region, New Zealand.
Hari Dass P; B Jameson M
Intern Med J; 2020 Nov; 50(11):1344-1349. PubMed ID: 31707758
[TBL] [Abstract][Full Text] [Related]
11. Testicular cancer: a narrative review of the role of socioeconomic position from risk to survivorship.
Richardson LC; Neri AJ; Tai E; Glenn JD
Urol Oncol; 2012; 30(1):95-101. PubMed ID: 22127018
[TBL] [Abstract][Full Text] [Related]
12. Personalizing, not patronizing: the case for patient autonomy by unbiased presentation of management options in stage I testicular cancer.
Oldenburg J; Aparicio J; Beyer J; Cohn-Cedermark G; Cullen M; Gilligan T; De Giorgi U; De Santis M; de Wit R; Fosså SD; Germà-Lluch JR; Gillessen S; Haugnes HS; Honecker F; Horwich A; Lorch A; Ondruš D; Rosti G; Stephenson AJ; Tandstad T
Ann Oncol; 2015 May; 26(5):833-838. PubMed ID: 25378299
[TBL] [Abstract][Full Text] [Related]
13. Comparative Effectiveness of Surveillance, Primary Chemotherapy, Radiotherapy and Retroperitoneal Lymph Node Dissection for the Management of Early Stage Testicular Germ Cell Tumors: A Systematic Review.
Pierorazio PM; Cheaib JG; Patel HD; Gupta M; Sharma R; Zhang A; Tema G; Bass EB
J Urol; 2021 Feb; 205(2):370-382. PubMed ID: 32915080
[TBL] [Abstract][Full Text] [Related]
14. Factors that impact the outcomes in testicular germ cell tumors in low-middle-income countries.
Saju SV; Radhakrishnan V; Ganesan TS; Dhanushkodi M; Raja A; Selvaluxmy G; Sagar TG
Med Oncol; 2019 Feb; 36(3):28. PubMed ID: 30725328
[TBL] [Abstract][Full Text] [Related]
15. Trends in incidence and results of treatment of testicular germ cell tumours in Finland 1972-1983.
Halme A; Kellokumpu-Lehtinen P; Lehtonen T
Acta Oncol; 1989; 28(6):777-83. PubMed ID: 2558693
[TBL] [Abstract][Full Text] [Related]
16. Modern Management of Testicular Cancer.
Chen J; Daneshmand S
Cancer Treat Res; 2018; 175():273-308. PubMed ID: 30168127
[TBL] [Abstract][Full Text] [Related]
17. Part I: testicular cancer--management of early disease.
Jones RH; Vasey PA
Lancet Oncol; 2003 Dec; 4(12):730-7. PubMed ID: 14662429
[TBL] [Abstract][Full Text] [Related]
18. Adverse prognostic factors for testicular cancer-specific survival: a population-based study of 27,948 patients.
Fosså SD; Cvancarova M; Chen L; Allan AL; Oldenburg J; Peterson DR; Travis LB
J Clin Oncol; 2011 Mar; 29(8):963-70. PubMed ID: 21300926
[TBL] [Abstract][Full Text] [Related]
19. Contemporary Incidence and Mortality Rates in Patients With Testicular Germ Cell Tumors.
Palumbo C; Mistretta FA; Mazzone E; Knipper S; Tian Z; Perrotte P; Antonelli A; Montorsi F; Shariat SF; Saad F; Simeone C; Briganti A; Lattouf JB; Karakiewicz PI
Clin Genitourin Cancer; 2019 Oct; 17(5):e1026-e1035. PubMed ID: 31378580
[TBL] [Abstract][Full Text] [Related]
20. Trends in testicular germ cell cancer incidence in Eastern Croatia.
Sudarević B; Radoja I; Šimunović D; Kuveždić H
Med Glas (Zenica); 2014 Feb; 11(1):152-8. PubMed ID: 24496357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
